Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Aspen's Parkinson's cell therapy data plant seeds for ph. 3
Eight out of eight patients saw marked improvements in measures of symptom control, motor function and quality of life one year after treatment.
Darren Incorvaia
Mar 18, 2026 9:00am
After $1B fundraise, Xaira breaks silence on AI work
Mar 17, 2026 2:52pm
Stop asking for an AI strategy: 3 questions clinical leaders should ask instead
Brought to you by
Syneos Health
FDA, NIH pledge flexibility and $150M for animal alternatives
Mar 18, 2026 9:00am
How physiology powers biotech innovation
Brought to you by
American Physiological Society
Crossbow hits $77M series B round to bankroll quiver of T-Bolts
Mar 18, 2026 10:50am
More News
Stroke tech developer Imperative Care nets $100M financing
Mar 18, 2026 10:50am
Fierce Biotech Fundraising Tracker '26: Crossbow, R1 & more
Mar 18, 2026 10:30am
JenaValve secures FDA's 1st approval in aortic regurgitation
Mar 18, 2026 10:05am
Fierce Biotech Layoff Tracker 2026: Gossamer, Bicycle & more
Mar 18, 2026 9:00am
See more stories